Autonomic Nervous System
Device

PATIENTS WHO SHOULD BE TESTED, ACCORDING TO MEDICAL GUIDELINES


50+

Population over 50 years old with cardiovascular risk factors (Hypertensive, Overweight, Smoker, Diabetic)

70+

Everyone older than 70

Main Markers
medica-main-markers-website-2400w

PATIENT TEST


Medica Patient Test

STUDIES


MAIN CLINICAL STUDIES
PREVIOUS PUBLISHED STUDIES
R&D PUBLICATIONS
MAIN CLINICAL STUDIES

LEWIS ET AL.

New method of sudomotor function measurement to detect microvascular disease and sweat gland nerve or unmyelinated C fiber dysfunction in adults with retinopathy. Journal of Diabetes & Metabolic Disorders (2017) 16:26.


LOPEZ ET AL.

Relationship Between Vitamin D Status, Autonomic nervous system activity and Cardiometabolic Risk. Open Journal of internal medicine, 2017,7,37-51


DE SOUZA ET AL.

Assessment of insulin sensitivity by the hyperinsulinemic euglycemic clamp: Comparison with the spectral analysis of photoplethysmography. Journal of Diabetes and its complications. Volume 31, (2017) 128–133.


LEWIS ET AL.

A cross-sectional assessment to detect Type 2 Diabetes with endothelial and autonomic nervous system markers using a novel system. Journal of Diabetes & metabolic disorders, 2014,13:118​


GOBATO RC, SEIXAS CHAVES DF, CHAIM EA.

Micronutrient and physiologic parameters before and 6 months after RYGB. Surg Obes Relat Dis. 2014 Sep-Oct;10(5):944-51.


​​GANDHI PG, RAO GHR.

The spectral analysis of the photoplethysmography to evaluate an independent cardiovascular risk.Int J Gen Med. 2014 Dec 9;7:539-47.


GANDHI PG, RAO GHR.

Detection of neuropathy using a sudomotor test in type 2 Diabetes.Degenerative Neurological and Neuromuscular Disease. January 2015,5:1-7.​


MAAREK A A., GANDHI PG AND RAO GHR.

Identifying Autonomic Neuropathy and Endothelial Dysfunction in Type II Diabetic Patients. EC Neurology 2.2(2015): 63-78. ​


​​RAO GHR.

Non-Traditional Approaches to Diagnosis and Management of Type-2 Diabetes Mellitus: Point of View. J Diabetes Metab (2015) 6: 489.​


GUNDU HR RAO, PRATIKSHA G GANDHI AND VINEETA SHARMA.

Clinical Complications of Type-2 Diabetes Mellitus in South Asian and Chinese Populations: An Overview. J Diabetes Metab. Volume 5 • Issue 8.


​​GUNDU H R RAO, PRATIKSHA G GANDHI.

Need for a Noninvasive Diagnostic Platform for Early Detection and Management of Cardiometabolic Disorders. Journal of Clinical and Preventive Cardiology,July 2014 | Number 3. ​

PREVIOUS PUBLISHED STUDIES

LEWIS JEP, MELILLO AB, TANNENBAUM S, GAO J, LONG E, ALONSO Y, KONEFAL J, WOOLGER JM, LEONARD D, SINGH PK, CHEN L, TIOZZO E.

Validation of the EIS-GS, ESO and ES-BC. Comparing the accuracy of ES-BC, EIS and ES Oxi results versus the recognized standardized assessment. Medical Devices. Evidence and Research.September 2011.Volume 2011. 4p.169-177.


CHAIM E A, GOBATO RC-

LEWIS JEP, MELILLO AB, TANNENBAUM S, GAO J, LONG E, ALONSO Y, KONEFAL J, WOOLGER JM, LEONARD D, SINGH PK, CHEN L, TIOZZO E.


CHAIM E A, GOBATO R C, CARVALHO RAMOS M.

New Approach to beta cell function screening by nitric oxide assessment of obese individuals at the population level. International Journal of Internal Medicine May 2012 Volume 2012:5 Pages 449 - 454.

R&D PUBLICATIONS

MAAREK A.

Electro interstitial scan system: assessment of 10 years of research and development. Medical Devices: Evidence and Research. March 2012 Volume 2012:5 Pages 23 - 30.

F. CAUDAL

New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods. Psychology Research and Behavior Management » Volume 4, P.113-117.2011

VG ALEXEEV VG, LV KUZNECOV.

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment. Psychology Research and Behavior Management. p.81-86. Volume 4.2011.

Next Steps...

Ready to learn more about our Autonomic Nervous System Testing Equipment or Vascular Function Testing Equipment? Contact us today for a demo.

LD Technology is the TM-Flow manufacturer. The TM-Flow is a Medical Device Data System (MDDS) which manages the SweatC, TM-ABI, and LD-OXY Systems. FDA product code: OUG. FDA 510(k) k152216 approval for SweatC (aka SUDOC) Galvanic Skin Response related to the sweat gland function. FDA 510(k) k143152 approval for TM-ABI Volume Plethysmography for assessing symptomatic Peripheral Artery Disease. FDA 510(k) k160956 approval for Photoplethysmography analysis, Heart Rate Variability, and Cardiovascular Autonomic Reflex Test analysis.